Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Deficit (Details) - Schedule of option activity

v3.20.2
Stockholders' Deficit (Details) - Schedule of option activity - Options [Member]
9 Months Ended
Sep. 30, 2020
USD ($)
$ / shares
shares
Stockholders' Deficit (Details) - Schedule of option activity [Line Items]  
Option Number of Shares outstanding at beginning (in Shares) | shares 1,000,000
Option Weighted Average Exercise Price outstanding at beginning $ 0.75
Option Weighted Average Remaining Contractual Term outstanding at beginning 9 years 18 days
Option Aggregate Intrinsic Value outstanding at beginning (in Dollars) | $
Granted Number of Shares (in Shares) | shares 800,000
Granted Weighted Average Exercise Price $ 0.75
Granted Weighted Average Remaining Contractual Term 9 years 124 days
Granted Aggregate Intrinsic Value
Forfeited Number of Shares (in Shares) | shares
Forfeited Weighted Average Exercise Price
Forfeited Aggregate Intrinsic Value (in Dollars) | $
Exercised Number of Shares (in Shares) | shares
Exercised Weighted Average Exercise Price
Exercised Aggregate Intrinsic Value (in Dollars) | $
Expired Number of Shares (in Shares) | shares
Expired Weighted Average Exercise Price
Expired Aggregate Intrinsic Value (in Dollars) | $
Option Number of Shares outstanding at ending (in Shares) | shares 1,800,000
Option Weighted Average Exercise Price outstanding at ending $ 0.75
Option Weighted Average Remaining Contractual Term outstanding at ending 8 years 277 days
Option Aggregate Intrinsic Value outstanding at ending (in Dollars) | $ $ 513,000
Option Number of Shares exercisable at ending (in Shares) | shares 1,206,250
Option Weighted Average Exercise Price exercisable at ending $ 0.75
Option Weighted Average Remaining Contractual Term exercisable at ending 8 years 204 days
Option Aggregate Intrinsic Value exercisable at ending (in Dollars) | $ $ 343,781